T
Tesseract Health
Building a portable, affordable device for monitoring and preventing disease through the eye
About Tesseract Health
Identifeye Health leverages artificial intelligence to revolutionize the field of medical diagnostics by focusing on retinal imaging. The company has developed an innovative platform that allows non-specialists to capture and analyze retinal images in real-time, providing immediate health insights. This technology democratizes access to critical health information, enabling earlier diagnosis and treatment of diseases. Identifeye Health primarily serves healthcare providers, including clinics and hospitals, operating within the medical diagnostics market. The business model is based on selling its imaging platform and associated services to these healthcare providers. Revenue is generated through the sale of the platform, subscription fees for ongoing access to the AI algorithms, and potential partnerships with healthcare institutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Guilford, United States
- Employees
- 34
- Open positions
- None listed
- Dealroom signal
- 63.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Ophthalmology, Medical Imaging, Health Diagnostics, AI for medical imaging, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Tesseract Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Apr 2021 | $80M | $320M | Glenview Capital · Foresite Capital · Opaleye Management | — |
Growth signals
Latest recorded traffic for Tesseract Health is 2.3K monthly website visits, up 0% over the last three months. Tesseract Health's team declined 37% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Glenview Capital
Foresite Capital- OMOpaleye Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tesseract Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tesseract Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





